Olle Nilsson
Directeur Technique/Scientifique/R&D chez Fujirebio Diagnostics, Inc.
Profil
Olle Nilsson is currently the Director at CYTO365 AB and the Chief Scientific Officer & Vice President at Fujirebio Diagnostics, Inc. He previously worked as the Chairman at AcouSort AB, Chief Scientific Officer & Vice President at Fujirebio Diagnostics AB, Principal at Phadia AB, and Principal at the University of Gothenburg.
Dr. Nilsson holds a graduate degree from the University of Uppsala and a doctorate degree from the University of Gothenburg.
Postes actifs de Olle Nilsson
| Sociétés | Poste | Début |
|---|---|---|
Fujirebio Diagnostics, Inc.
 Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Directeur Technique/Scientifique/R&D | 01/05/2006 |
CYTO365 AB
 CYTO365 AB Medical SpecialtiesHealth Technology CYTO365 AB manufactures medical stopcock products for mixing of drugs. The company is based in Höganäs, Sweden. The Swedish company was founded by Micael Törnblom. Micael Törnblom has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
Anciens postes connus de Olle Nilsson
| Sociétés | Poste | Fin |
|---|---|---|
| ACOUSORT AB | Président | - |
Phadia AB
 Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Corporate Officer/Principal | - |
| University of Gothenburg | Corporate Officer/Principal | - |
Fujirebio Diagnostics AB
 Fujirebio Diagnostics AB Pharmaceuticals: MajorHealth Technology Fujirebio Diagnostics AB develops and manufactures immunological reagents. It focuses on the development of monoclonal antibodies which fight against biochemical markers of diseases. The firm distributes products to the international biotech and diagnostic industries. The company is headquartered in Gothenburg, Sweden. | Directeur Technique/Scientifique/R&D | - |
Formation de Olle Nilsson
| University of Uppsala | Graduate Degree |
| University of Gothenburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACOUSORT AB | Distribution Services |
| Entreprise privées | 4 |
|---|---|
Fujirebio Diagnostics AB
Fujirebio Diagnostics AB Pharmaceuticals: MajorHealth Technology Fujirebio Diagnostics AB develops and manufactures immunological reagents. It focuses on the development of monoclonal antibodies which fight against biochemical markers of diseases. The firm distributes products to the international biotech and diagnostic industries. The company is headquartered in Gothenburg, Sweden. | Health Technology |
Fujirebio Diagnostics, Inc.
Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Health Technology |
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Health Technology |
CYTO365 AB
CYTO365 AB Medical SpecialtiesHealth Technology CYTO365 AB manufactures medical stopcock products for mixing of drugs. The company is based in Höganäs, Sweden. The Swedish company was founded by Micael Törnblom. Micael Törnblom has been the CEO since incorporation. | Health Technology |
